Propel Bio Management LLC
Overview
Propel Bio Management LLC is a private investment firm specializing in biotechnology investments. The firm focuses on early-stage and growth-stage companies, aiming to advance groundbreaking technologies and therapies that improve human health. Propel Bio Management LLC provides discretionary investment advisory services to Propel Bio Partners, L.P., a private fund, and sub-advisory services to the Simplify Propel Bio Opportunities ETF. The firm's investment strategy emphasizes seed and venture capital investments in life sciences and related fields, leveraging deep scientific and business expertise to support entrepreneurial founders in the biotech sector. Propel Bio Management LLC is registered with the SEC and has assets under management totaling approximately $149 million.
Investment Focus
- Focus on biotechnology investments
- Target early-stage and growth-stage companies
- Emphasis on life sciences and related fields
Portfolio Companies
Reach Propel Bio Management LLC directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Propel Bio Management LLC
What sectors does Propel Bio Management LLC invest in?
Propel Bio Management LLC invests in Life Sciences and Biotechnology, and is based in California, United States. Propel Bio Management LLC is listed as a private investment firm in the ConnectSafely investor database.
What stage does Propel Bio Management LLC invest at?
Propel Bio Management LLC backs companies at Seed, Early Stage and Growth.
Which regions does Propel Bio Management LLC invest in?
Propel Bio Management LLC invests across United States.
What companies has Propel Bio Management LLC invested in?
Propel Bio Management LLC's portfolio includes Achieve Life Sciences Inc., Akero Therapeutics Inc. and Abeona Therapeutics Inc..
Last updated · Source: ConnectSafely investor database
